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Abstract: Aminoethylcysteine ketimine decarboxylated dimer is a natural sulfur-containing 
compound detected in human plasma and urine, in mammalian brain and in many common 
edible vegetables. Over the past decade many studies have been undertaken to identify its 
metabolic role. Attention has been focused on its antioxidant properties and on its reactivity 
against oxygen and nitrogen reactive species. These properties have been studied in different 
model systems starting from plasma lipoproteins to specific cellular lines. All these studies 
report that aminoethylcysteine ketimine decarboxylated dimer is able to interact both with 
reactive  oxygen  and  nitrogen  species  (hydrogen  peroxide,  superoxide  anion,  hydroxyl 
radical, peroxynitrite and its derivatives). Its antioxidant activity is similar to that of Vitamin 
E while higher than other hydrophilic antioxidants, such as trolox and N-acetylcysteine.  
Keywords:  sulfur-containing  antioxidants;  aminoethylcysteine  ketimine  decarboxylated 
dimer; reactive oxygen species; reactive nitrogen species 
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1. Introduction  
Oxygen is the key molecule which enables aerobic metabolism in living organisms. However, due 
to  its  high  reactivity,  it  is  also  able  to  damage  bio-molecules  by  producing  reactive  oxygen 
species (ROS) [1]. For this reason living organisms have developed a large and complex network of 
antioxidant molecules and enzymes, able to protect cellular components such as nucleic acids, proteins 
and lipids from oxidative damage. 
According to a general definition, antioxidants can slow down or prevent the oxidation of other 
molecules by removing free radical intermediates. Cellular antioxidants can mainly act in two ways:  
(i) preventing these reactive species from being formed, or (ii) inactivating them before they are able to 
damage cellular components [2–5]. ROS production occurs physiologically during aerobic metabolism 
and the main role of the antioxidant network present within the cell is to buffer their overproduction, 
by keeping them at a level where their physiological role can be carried out (i.e., redox signaling) [6]. 
An imbalance of the antioxidant system may cause severe cellular damage and lead to oxidative stress 
condition,  which  is  often  involved  in  the  pathogenesis  of  important  diseases,  such  as  cancer  and 
atherosclerosis. This imbalance is also implicated in other pathological conditions (such as malaria and 
rheumatoid arthritis) and could play a role in neurodegenerative diseases and ageing processes [7].  
In the last decades, research has been focused on prevention of oxidative damage. The molecular 
mechanisms involved in the radical scavenging activity of many natural antioxidants and the role they 
have in human health have been extensively studied. A lot of attention has been focused on dietary 
antioxidants  (α-tocopherol,  β-carotene,  ascorbic  acid),  as  they  may  act  together  with  endogenous 
antioxidant  metabolites  and  enzymes  (superoxide  dismutase,  glutathione  peroxidase,  catalase)  in 
reducing ROS level. Several epidemiological studies have already highlighted that a high intake of 
plant products rich in antioxidants is associated with a reduced risk of a number of severe chronic 
diseases, such as atherosclerosis and cancer. The protection that fruits and vegetables provide against 
several diseases has been attributed to various antioxidants present in these species, such as vitamin C, 
vitamin E, α-tocopherol, β-carotene and polyphenolic compounds [8–11].  
Related studies have also shown that many of these antioxidant compounds show anti-inflammatory, 
anti-atherosclerotic, antimutagenic, anticarcinogenic, antibacterial, or antiviral activities to a greater or 
lesser extent [12–15]. 
In recent years the work of our research group has been focused on a small group of natural sulfur-containing 
iminoacids deriving from L-cystathionine, L-lanthionine and (S)-2-aminoethyl-L-cysteine [16]. All of them 
have been identified in biological tissues and fluids but, until now, their biological function is still 
unclear [17–24]. Among these compounds, aminoethylcysteine ketimine decarboxylated dimer was also 
detected in many edible vegetables [25] and, while a physiological role has not yet been described for 
this  molecule,  its  antioxidant  properties  have  been  extensively  explored  and  are  described  in  
this review. 
2. Sulfur-Containing Antioxidants 
Sulfur  plays  a  critical  role  in  biology,  it  is  widely  distributed  among  living  organisms  and, 
particularly, is found in many peptides, proteins and low molecular weight compounds [26,27]. Among Int. J. Mol. Sci. 2011, 12                       
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the sulfur species found in plants, bacteria, fungi and animals, there are many agents with unique 
chemical and biochemical properties, which are linked to redox processes, metal binding and catalytic 
reactions.  The  antibiotic  and  anticarcinogenic  properties  of  sulfur  compounds  such  as  thiols, 
thiosulfinates, thiosulfonates, isothiocyanates, sulfoxides, sulfones, sulfinates and polysulfides make 
them  interesting  from  a  pharmacological  perspective  [28].  The  full  impact  of  sulfur  in  biological 
systems becomes evident when one considers the diversity of sulfur species and the reactions in which 
sulfur is involved. These reactions are the result of: (i) the range of different oxidation states sulfur can 
occupy in vivo; (ii) the abundance of different chemotypes possible for each oxidation state; (iii) the 
various chemical properties that each chemotype exhibits in addition to redox activity, i.e., electrostatic 
interactions, hydrogen bonding, acid-base properties, nucleophilicity and electrophilicity, metal-binding 
and catalysis. Among these properties, redox-activity, metal binding and nucleophilic substitution are 
the mechanism most frequently employed by cells to remove oxidative stressors, adventitious metal 
ions and toxic substances [26,27]. 
The best investigated sulfur-containing antioxidant compounds are, cysteine, methionine, taurine, 
glutathione, lipoic acid, mercaptopropionylglycine and N-acetylcysteine [29].  
In recent years, increasing attention has been focused on the discovery of new physiological sulfur 
compounds that show antioxidant activities. Among these, a very interesting one is aminoethylcysteine 
ketimine decarboxylated dimer (Figure 1), which is a member of a group of eterocyclic ketimines 
containing  sulfur  and  nitrogen  arising  from  the  metabolism  of  L-cystathionine,  L-lanthionine  and  
(S)-2-aminoethyl-L-cysteine [16]. Many of these ketimines and their derivatives have been found in 
detectable amounts in mammalian tissues and fluids [17–24]. 
Figure 1. Aminoethylcysteine ketimine decarboxylated dimer. 
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3. Aminoethylcysteine Ketimine Decarboxylated Dimer 
The chemical synthesis of 1 was first achieved by Hermann and coworkers in 1961 in very good 
yields starting from cysteamine and bromopyruvic acid [30]. 
Over  the  past  several  years,  this  molecule  has  been  detected  in  many  mammalian  tissues  and 
fluids (human plasma, 2–3 µ M, [22], human urine [23] and in bovine cerebellum, 0.6–1 nmol/g wet  
weight [24]). Recently it was also identified in the brain of cysteamine-treated rats [31]. These findings 
seem particularly important because they allow formulating new hypotheses on the metabolic origin of 
this molecule. According to Pinto and coworkers [31], 1 cannot be detected in the brain of rats that are 
not fed a cysteamine-supplemented diet, suggesting that the brain has the capacity to synthesize 1 
when supplied with an adequate amount of this aminothiol. Int. J. Mol. Sci. 2011, 12                       
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In fact, although a metabolic route leading to in vivo formation of 1 has not been identified yet, one 
of the current hypotheses is that it can be formed in vivo from the dimerization of aminoethylcysteine 
ketimine (2), followed by a spontaneous decarboxylation step [20] (Scheme 1). 
Scheme 1. Hypothetical pathway leading to the in vivo synthesis of 1. 
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Compound 2 can be endogenously synthesized starting from cysteamine and serine in a two-steps 
biosynthetic path involving cystathionine β-synthase and glutamine transaminase [32]. 
As 1 has been detected in many common Mediterranean edible vegetables (where it is present at a 
concentration  range  of  nmol/g  plant  material),  it  can  be  alternatively  considered  a  vitamin-like 
compound being introduced in the diet. 
Besides efforts to detect this molecule in biological samples, over the past decade many studies 
have been undertaken to identify its metabolic role. Attention has been focused on its antioxidant 
properties and on its reactivity against oxygen and nitrogen reactive species. These properties have 
been studied in different model systems starting from plasma lipoproteins to specific cellular lines. 
All these studies report that 1 is able to interact with reactive oxygen and nitrogen species (hydrogen 
peroxide, superoxide anion, hydroxyl radical, peroxynitrite and its derivatives) [33–36] in all the tested 
models.  In  addition,  in  order  to  understand  the  molecular  mechanism  underlying  its  antioxidant 
properties, research efforts have been focused on the oxidation products of 1. Until now three different 
products have been isolated and characterized [37–39], while several others need further analyses to be 
identified. As expected, sulfur plays a key role in the antioxidant properties of 1. Each sulfur atom can 
be oxidized to sulfoxide and subsequently to sulfone, leading to the formation of several oxidized 
species. In addition, a dimeric form and a dehydrogenated product of 1 were also detected, suggesting 
that the molecular architecture is as important as the presence of sulfur groups. 
3.1. Aminoethylcysteine Ketimine Decarboxylated Dimer as Scavenger of Reactive Oxygen Species 
Various  processes  inside  the  cell  produce  reactive  oxygen  species  (ROS).  Some  of  the  most 
common ROS are hydrogen peroxide (H2O2), superoxide ion (O2
−), hydroxide and hydroxyl ions (OH
− 
and OH- respectively). Compound  1 is able to quench ROS leading to the formation of different 
oxidative  products.  In  Scheme  2  two  oxidation  products  of  1,  which  have  been  isolated  and 
characterized so far, are shown. 
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Scheme  2.  Oxidation  products  of  aminoethylcysteine  ketimine  decarboxylated  dimer. 
Reagents  and  conditions:  (i)  CuCl2/t-BOOH  or  2,2'-azo-bis-2-amidinopropane-HCl,  
(ii) hydrogen peroxide. 
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Compound  4,  which  shows  an  additional  unsaturation  with  respect  to  1,  may  arise  from  an 
oxidative dehydrogenation path that involves the carbons 10 and 10a of the tricyclic structure. This 
molecule  is  formed  in  vitro  in  the  presence  of  CuCl2/tert-butyl  hydroperoxide  (t-BOOH)  or  
2,2'-azo-bis-2-amidinopropane  hydrochloride  [37].  Compound  5  is  produced  when  1  reacts  with 
hydrogen peroxide [38]. 
Several other species have been identified by GC-MS but not yet unambiguously characterized. 
Among these, the chromatographic analysis shows the presence of at least four different oxidation 
products,  whose  mass  and  fragmentation  patterns  suggest  the  formation  of  1-sulfone,  4-sulfoxide,  
4-sulfone and hydroxyl-1, on the basis of that reported by Pecci et al. [38]. 
As already mentioned, endogenous ROS are known to play an important role in ethiopathogenesis 
of some common and severe chronic diseases, such as atherosclerosis.  
Besides the in vitro studies carried out to test the quenching activity of 1 towards ROS, ex vivo 
assays on isolated human low-density lipoproteins (LDL) were performed. It is known that oxidation 
of LDL is an important event implicated in the pathogenesis of atherosclerosis [40]. Oxidized LDL 
that are no longer recognized by the LDL receptor of the macrophages, are internalized in these cells, 
via the scavenger receptor pathway, leading to the formation of foam cells [41,42]. The resistance of 
LDL to oxidative modification is linked to its fatty acids composition and to circulating levels of 
antioxidant compounds [43]. 
Compound 1 has already been found to be associated to plasma lipoproteins in humans [22], while 
another  study  demonstrated  its  efficacy  in  inhibiting  the  copper-catalyzed  oxidation  of  human  
LDL [44]. Cu
2+ catalyzes the lipoprotein oxidation in two main ways: (i) at the protein moiety level [45]; 
(ii) at the lipid moiety level, via decomposion of pre-existing lipid hydroperoxides and generation of 
peroxyl- and alkoxyl radicals, which initiate lipid peroxidation [46–48]. Since 1 shows scavenging 
activity  against  peroxyl  (or  alkoxyl)  radicals,  the  main  propagating  species  involved  in  the  LDL 
lipoperoxidation,  it  seems  reasonable  to  hypothesize  that  this  could  be  the  possible  molecular Int. J. Mol. Sci. 2011, 12                       
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protection mechanism carried out by 1 against LDL oxidation. The biological relevance of this study is 
that AECK-DD is active at concentrations comparable to those found in human plasma [22]. For this 
reason AECK-DD antioxidant properties were also tested on a human U937 monocytic cell line in the 
presence of the oxidant t-BOOH [49]. 
In  fact,  it  has  been  recognized that  monocyte-endothelium  adhesion  is  a  crucial early  event in 
atherogenesis  and  that  plasma  antioxidants  can  prevent  or  reduce  it  [50,51].  U937  is  a  well 
characterized cell line and the response of this cell line to various inflammatory agents has been well 
documented [52,53]. 
The  antioxidant  activity  of  1  is  carried  out  within  the  U937  cells,  as  its  uptake  has  been 
demonstrated by HPLC-ECD and GC-MS analyses [49,54]. A 24 h treatment with 50 and 250 µ M 
AECK-DD, resulted in the incorporation of 0.10 ±  0.01 and 0.47 ±  0.08 ng AECK-DD ×  10 [6] cells 
respectively  [49].  In  addition,  1  did  not  display  any  cytotoxic  effect  up  to  the  range  of  mM 
concentration in the culture medium. Further, at this concentration level, no pro-apoptotic effect has 
been  observed  by  DNA  fragmentation  measurements  [49].  Compound  1  in  concentration  range  
4–100 µ M protects U937 cells from oxidative injury, as revealed by the higher viability maintained 
with  respect  to  control  cells  during  t-BOOH  treatment.  It  is  reported  that  low  concentrations  of  
t-BOOH  lethally  affect  cultured  cells  by  a  mechanism  that  is  dependent  on  the  cellular  lipids 
peroxidation [55]. Therefore, an association of 1 to cellular membranes due to its hydrophobicity could 
explain  its  high  efficiency  in  protecting  cells  against  t-BOOH-induced  oxidative  injury.  The 
antioxidant activity of 1 was compared with other known antioxidants with similar results to that of 
vitamin E, and higher than other hydrophilic antioxidants tested (trolox and N-acetylcysteine). The 
results  obtained  by  Macone  and  coworkers  [49]  indicated  that  the  ability  of  1  to  protect  human 
monocytic U937 cells from t-BOOH-induced oxidative stress seems to be mediated by its ability to 
maintain both intracellular glutathione levels and a reducing environment inside the cell, and to slow 
down the onset of lipid peroxidation. 
The protective effect of 1 might be due to a direct quenching of free radicals, produced during  
t-BOOH  treatment,  by  1  itself.  Moreover,  data  indicate  that  1  is  able  to  significantly  reduce  the 
intracellular level of pro-oxidant species in U937 cells in basal conditions. Such studies demonstrated 
for the first time an antioxidant action of 1 inside the cells, and its ability to modulate cellular response 
to oxidative stress. As already mentioned, the concentration of 1 in which its antioxidant activity is 
carried  out,  is  in  the  range  of  that  measured  in  human  plasma  from  healthy  subjects  in  fasting 
conditions [22]. In addition, due to the presence of 1 in human diet, the physiological concentrations of 
this molecule in non-fasting conditions may be expected to be even higher than those measured in 
fasting humans. Therefore it can be suggested that, at the concentrations present in human plasma, 1 
can really play a significant role in the modulation of oxidative processes in vivo. 
3.2. Aminoethylcysteine Ketimine Decarboxylated Dimer as Scavenger of Reactive Nitrogen Species 
Reactive nitrogen species (RNS) are a family of molecules derived from nitric oxide (
•NO) [56]. In 
particular, the product of the diffusion-controlled reaction between nitric oxide (
•NO) and superoxide 
anion (O2
−) is peroxynitrite (ONOO
−/ONOOH), a strong oxidizing and nitrating agent that reacts with Int. J. Mol. Sci. 2011, 12                       
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several  biomolecules  [57–63].  Besides  its  activity  as  oxidative  process  modulator,  a  scavenging 
activity on peroxynitrite has been described for 1 [36].  
Peroxynitrite  is  an  endogenous  mediator  of  various  forms  of  tissue  damage  in  several  human 
pathologies,  including  neurodegenerative  diseases,  atherosclerosis,  inflammatory  and  autoimmune 
diseases. [64,65]. Peroxynitrite is known to mediate oxidation of suitable substrates, either through a 
direct two-electron mechanism or through an indirect one-electron reaction involving hydroxyl (
•OH) 
and  nitrogen  dioxide  (
•NO2)  radicals  released  during  peroxynitrite  homolysis  [59,66–68].  Under 
physiological  conditions,  peroxynitrite  predominantly  reacts  with  carbon  dioxide  [69]  and  the 
oxidative  reactions  of  peroxynitrite  are  mediated  by  (i)  the  carbonate  radical  anion  (CO3
•−); 
(ii) 
•NO2  generated  by  decomposition  of  the  short-lived  peroxynitrite-CO2  adduct  [70–72].  After 
reaction with peroxynitrite, 1 undergoes oxidative modifications, yielding a dimeric form of the parent 
compound (6) (Scheme 3), which has so far been isolated and characterized using 1D and 2D nuclear 
magnetic resonanceand ion trap mass spectrometry [39]. The proposed mechanism for the formation of 
the peroxynitrite-oxidation derivative of 1 involves the radical dimerization of 1 [39]. 
Scheme 3. Production of a dimeric form of aminoethylcysteine ketimine decarboxylated 
dimer in the presence of peroxynitrite. Reagents and conditions: (i) peroxynitrite. 
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Peroxynitrite induces lipid peroxidation [73], oxidizes protein and non-protein thiol groups [61,74] 
and reacts with tyrosine to yield 3-nitrotyrosine [62]. The occurrence of 3-nitrotyrosine is considered 
the molecular footprint left by reaction of RNS with biomolecules [75,76], while nitrated tyrosine 
residues  are  actually  considered  as  biomarkers  in  a  variety  of  pathophysiological  conditions.  In 
addition, peroxynitrite can oxidize free methionine [77] and methionine residues in proteins, e.g., in 
the α1-antiproteinase (α1AP), where the oxidation of a critical methionine residue destroys the α1AP 
activity  [78].  Peroxynitrite  also  plays  a  role  in  the  oxidation  of  low  density  lipoprotein  [79].  Its 
generation in vivo leads to oxidative modification of blood lipoprotein, which is thought to be a critical 
event in the development of cardiovascular diseases, including atherosclerosis [40–43]. 
Tyrosine, when exposed to peroxynitrite at neutral pH, undergoes nitration to form 3-nitrotyrosine. 
Compound  1  decreases  the  peroxynitrite-mediated  tyrosine  nitration  in  a  concentration-dependent 
manner.  In  the  µ M  range  concentration  of  1,  reduction  of  nitration  was  higher  than  50%.  At 
higher (100 µ M) concentration, the nitration is even completely prevented. Compared with other sulfur 
compounds  with  established  antioxidant  activity,  1  showed  a  protective  effect  similar  to  that  of 
glutathioneand N-acetylcysteine, but higher than that of methionine [36]. Int. J. Mol. Sci. 2011, 12                       
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As reported above, peroxynitrite
 can oxidize methionine residues in proteins. Treatment of α1AP with 
peroxynitrite  causes  a  strong  reduction  in  its  elastase  inhibitory  capacity,  as  a  consequence  of  the 
oxidation of a critical methionine [78]. Compound 1 was able to carry out complete protection against 
α1AP inactivation, even at concentrations much lower than those of peroxynitrite. Compound 1 did not 
show any protective effect if added to α1AP preincubated with peroxynitrite, indicating that 1 did not 
reverse but prevent α1AP inactivation by scavenging peroxynitrite and/or its decomposition products [36]. 
It has been previously reported that peroxynitrite is able to oxidatively modify LDL [79]. LDL 
preincubation  with  1  before  peroxynitrite  addition  clearly  demonstrated  the  effectiveness  of  1  in 
decreasing peroxynitrite-mediated LDL oxidation. Compound 1 was able to prevent the oxidation of 
LDL almost completely. [36]. 
These results showed that 1 is a powerful scavenger of peroxynitrite and/or its derived species as it 
could  efficiently  protect  tyrosine  against  nitration,  α1AP  against  inactivation  and  LDL  against 
modification.  At  present  these  data  do  not  give  indications  about  the  mechanism  of  protection. 
Compound  1  could  act  by  directly  scavenging  peroxynitrite  or  via  a  combination  with  reactive 
intermediates of peroxynitrite decomposition. 
4. Conclusions 
Over  the  past  decade  many  studies  have  been  undertaken  to  identify  the  metabolic  role  of 
aminoethylcysteine ketimine decarboxylate dimer, a natural sulfur-containing compound detected in 
human plasma and urine, mammalian brain and in many common edible vegetables. Attention has 
been focused on its antioxidant properties and on its reactivity against oxygen and nitrogen reactive 
species. All the reviewed studies report that aminoethylcysteine ketimine decarboxylate dimer is able 
to  interact  both  with  reactive  oxygen  and  nitrogen  species  (hydrogen  peroxide,  superoxide  anion, 
hydroxyl  radical,  peroxynitrite  and  its  derivatives)  protecting  human  low-density  lipoprotein  and 
cultured monocytes against oxidative injury. In these model systems, its antioxidant activity produced 
similar results to that of Vitamin E and higher than other hydrophilic antioxidant, such as trolox and  
N-acetylcysteine. In addition, 1 is able to quench ROS and RNS leading to the formation of different 
oxidative products that have been isolated and characterized. The study of several other oxidation 
products will lead to a better understanding of the molecular mechanism that underlies its powerful 
action as an antioxidant. 
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